MedPath

SMART Trial: Community Stigma Reduction

Not Applicable
Completed
Conditions
Stigma, Social
Opioid-use Disorder
Registration Number
NCT05075330
Lead Sponsor
Karen Derefinko, PhD
Brief Summary

The goal of this project is to engage community members from two low-income African American communities (N=200) in a survey study that assesses stigma toward those with Opioid Use Disorder (OUD). Those from the intervention community will be subject to a stigma reduction campaign via billboards. Those from the control community will not. Stigma will be re-assessed following the period of the campaign.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
199
Inclusion Criteria
  • Identify as African American or Mixed race
  • Reside in Frayser or Orange Mound Communities
  • Access to telephone for follow-up assessment
Exclusion Criteria
  • Unable to understand consent procedures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Stigma scoreChange from baseline stigma score at 8 weeks

Pre- and post-intervention stigma assessments using the Exposure to Drug Users Index, Drug Use Stigmatization Scale, and the Stigma of Drug Users Scale

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

University of Tennessee Health Science Center

🇺🇸

Memphis, Tennessee, United States

University of Tennessee Health Science Center
🇺🇸Memphis, Tennessee, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.